Peer-Reviewed Journal Details
Mandatory Fields
McCarthy, Carol A.; Faisal, Waleed; O'Shea, Joseph P.; Murphy, Colm; Aherne, Robert J.; Ryan, Katie B.; Griffin, Brendan T.; Crean, Abina M.
2017
March
Journal Of Controlled Release
In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation
Published
()
Optional Fields
Mesoporous silica Dissolution Transfer model Hydrodynamics Supersaturation In vitro in vivo relationship (IVIVR) Fenofibrate
250
86
95
Drug release from mesoporous silica systems has been widely investigated in vitro using USP Type II (paddle) dissolution apparatus. However, it is not clear if the observed enhanced in vitro dissolution can forecast drug bioavailability in vivo. In this study, the ability of different in vitro dissolution models to predict in vivo oral bioavailability in a pig model was examined. The fenofibrate-loaded mesoporous silica formulation was compared directly to a commercial reference product, Lipantil Supra®. Three in vitro dissolution methods were considered; USP Type II (paddle) apparatus, USP Type IV (flow-through cell) apparatus and a USP IV Transfer model (incorporating a SGF to FaSSIF-V2 media transfer). In silico modelling, using Gastroplus™, to generate in vitro/in vivo relationships was also investigated. The study demonstrates that the in vitro dissolution performance of a mesoporous silica formulation varies depending on the dissolution apparatus utilised and experimental design. The findings show that the USP IV transfer model was the best predictor of in vivo bioavailability. The USP Type II (paddle) apparatus was not effective at forecasting in vivo behaviour. This observation is likely due to hydrodynamic differences between the two apparatus and the ability of the transfer model to better simulate gastrointestinal transit. The transfer model is advantageous in forecasting in vivo behaviour for formulations which promote drug supersaturation and as a result are prone to precipitation to a more energetically favourable, less soluble form. The USP IV transfer model could prove useful in future mesoporous silica formulation development. In silico modelling has the potential to assist in this process. However, further investigation is required to overcome the limitations of the model for solubility enhancing formulations.
0168-3659
https://doi.org/10.1016/j.jconrel.2016.12.043
10.1016/j.jconrel.2016.12.043
Grant Details
Science Foundation Ireland
Synthesis and Solid State Pharmaceutical Centre (SSPC) and Science Foundation Ireland (SFI) under grant number 12/RC/2275